Overview

  • Product nameAnti-CD45R antibody [IVA103]
    See all CD45R primary antibodies
  • Description
    Mouse monoclonal [IVA103] to CD45R
  • Tested applicationsSuitable for: IP, Flow Cytmore details
  • Species reactivity
    Reacts with: Cow
  • Immunogen

    Cow leukocytes.

Properties

Applications

Our Abpromise guarantee covers the use of ab9525 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IP
Flow Cyt
  • Application notesFlow Cyt: Use at an assay dependant concentration.
    IP: Use at an assay dependant concentration.

    Not tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • FunctionProtein tyrosine-protein phosphatase required for T-cell activation through the antigen receptor. Acts as a positive regulator of T-cell coactivation upon binding to DPP4. The first PTPase domain has enzymatic activity, while the second one seems to affect the substrate specificity of the first one. Upon T-cell activation, recruits and dephosphorylates SKAP1 and FYN.
    • Involvement in diseaseDefects in PTPRC are a cause of severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-positive (T(-)B(+)NK(+) SCID) [MIM:608971]. A form of severe combined immunodeficiency (SCID), a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. Patients present in infancy recurrent, persistent infections by opportunistic organisms. The common characteristic of all types of SCID is absence of T-cell-mediated cellular immunity due to a defect in T-cell development.
      Genetic variations in PTPRC are involved in multiple sclerosis susceptibility (MS) [MIM:126200]. MS is a neurodegenerative disorder characterized by the gradual accumulation of focal plaques of demyelination particularly in the periventricular areas of the brain. Peripheral nerves are not affected. Onset usually in third or fourth decade with intermittent progression over an extended period. The cause is still uncertain.
    • Sequence similaritiesBelongs to the protein-tyrosine phosphatase family. Receptor class 1/6 subfamily.
      Contains 2 fibronectin type-III domains.
      Contains 2 tyrosine-protein phosphatase domains.
    • DomainThe first PTPase domain interacts with SKAP1.
    • Post-translational
      modifications
      Heavily N- and O-glycosylated.
    • Cellular localizationMembrane. Membrane raft. Colocalized with DPP4 in membrane rafts.
    • Information by UniProt
    • Alternative names
      • B220 antibody
      • CD45 antibody
      • CD45 antigen antibody
      • Glycoprotein antibody
      • GP180 antibody
      • L CA antibody
      • L-CA antibody
      • LCA antibody
      • Leukocyte common antigen antibody
      • Leukocyte common antigen precursor antibody
      • loc antibody
      • Ly-5 antibody
      • LY5 antibody
      • Lyt-4 antibody
      • Protein tyrosine phosphatase receptor type C antibody
      • Protein tyrosine phosphatase receptor type c polypeptide antibody
      • Ptprc antibody
      • PTPRC_HUMAN antibody
      • Receptor type tyrosine protein phosphatase C antibody
      • Receptor-type tyrosine-protein phosphatase C antibody
      • T200 antibody
      • T200 glycoprotein antibody
      • T200 leukocyte common antigen antibody
      see all

    References for Anti-CD45R antibody [IVA103] (ab9525)

    This product has been referenced in:

    See all 3 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab9525.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"